Aa
Aa
A
A
A
Close
198419 tn?1360242356

New DMD Oral Therapy Study: CONFIRM Trial Phase 3

Keeping up on topic wants (studies)...Oral versus injection is down right exciting!

http://www.mscare.org/cmsc/News/CMSC-INForMS-Biogen-Idec-Announces-Positive-Top-Line-Results-from-2nd-PIII-Trial-of-Oral-BG-12.

"BG-12 met the CONFIRM study's primary endpoint by significantly reducing annualized relapse rate (ARR) by 44 percent for BID (p< 0.0001) and by 51 percent for TID (p< 0.0001) versus placebo at two years. The CONFIRM study's reference comparator, glatiramer acetate (GA; 20 mg subcutaneous daily injection), reduced the ARR by 29 percent (p< 0.02) compared with placebo at two years..."

Like Gilenya, the future will tell what impact the new oral DMDs (and BG-12 above) will have on MS, and the quality of the lives for those who are on them - but for now, I'm definitely excited.

-Shell
9 Responses
Sort by: Helpful Oldest Newest
198419 tn?1360242356
Max-C - That's how I read it. It's not to say the traditionals are not still good - they have the longest track record, and no new med can take that away - but this progress in meds makes me so hopeful for the future impact on MS - yay!

fwiw - There is another study update on the MS Consortium with a late stage trial that is showing better results too as compared to Rebif, but that's not an oral.

Aftermarket will tell the tale on these future meds for sure - and also how tolerable they are, side affects, etc....  
-shell

Helpful - 0
1816210 tn?1327354884
Am I understanding that correctly?  Does the study indicate greater success with the new oral drug than with copaxone?
Helpful - 0
572651 tn?1530999357
I took the period out of the link and I can see it now!  go figure................  :-)
Helpful - 0
198419 tn?1360242356
fyi - Including the period at the end of the link...
Helpful - 0
198419 tn?1360242356
Lu - may be your browser, because I just checked it again. Copy it in it's entirety, and paste directly into your browser........

Helpful - 0
Avatar universal
My Dr is putting me on the BG-12 I think as soon as it comes out.  She says it is really a promising choice for those like me who are not having luck with injections or infusions.

Actually she had a few words to say about the FDA holding back on it as it is a MUCH safer drug than fingolimoid of gilenya.

Oh the future is looking brighter every year for us :)
D
Helpful - 0
352007 tn?1372857881
I'm excited for you all too if you all decide should go that route!  Sounds promising doesn't it?

However, I wonder if people would want to switch to oral after doing years of injections or receiving infusions and feel they may be taking a risk by going off what was working for them to begin with?

Helpful - 0
572651 tn?1530999357
Shell, those links are not working for me.  We may need to find another article to link.  From what I read, the results of this trial made many people at ECTRIMS go "WOW!!"  The results were far superior than they had hoped for.

Helpful - 0
198419 tn?1360242356


             http://www.mscare.org/cmsc/News/CMSC-INForMS-Biogen-Idec-Announces-Positive-Top-Line-Results-from-2nd-PIII-Trial-of-Oral-BG-12.

If this link is not hot - copy and paste into browser :(
Helpful - 0
Have an Answer?

You are reading content posted in the Multiple Sclerosis Community

Top Neurology Answerers
987762 tn?1671273328
Australia
5265383 tn?1669040108
ON
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease